OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

M&A Transactions

M&A Transaction Chart

Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.

Week ended 09/29/2023

Week ended 09/29/2023

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

M&A Transactions Commentary

Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.

Week ended 09/29/2023

  • The Only Closed M&A Deal of the Week:
  • On September 29, 2023, Psilobrain, a private Canadian Biotech/Pharma company, announced the closing of its acquisition of U.K.-based Vitality CBD Limited, a subsidiary of Yooma Wellness (YOOM: CSE)(YOOM: AQSE) for total consideration of $2M.
  • After the sale, Yooma will no longer have any substantial operating assets and is facing a liquidity crisis.

Week ended 09/29/2023

This is the MA basic

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.